Scientists once hoped that blocking β-secretase would slow or prevent Alzheimer’s disease. Then came the rude awakening. The inhibitors caused the very thing they were supposed to prevent—cognitive ...

Eli Lilly is dropping a BACE inhibitor that was being tested in Alzheimer’s disease in combination with a second drug, a monoclonal antibody that binds to amyloid deposits in the brain. The news, ...

CHARLOTTE, NC--(Marketwired - Feb 17, 2015) - BACE, a global manufacturer of balers and compactors for the recycling and waste-disposal industries, has entered a strategic investment partnership with ...

JAM Capital Partners has agreed to make an investment in BACE, a Charlotte, North Carolina-based maker of balers and compactors for the recycling and waste-disposal sectors. No financial terms were ...

Detailed clinical and biomarker data say lanabecestat trial worked, the drug did not. All eyes are now on elenbecestat and umibecestat. These two compounds are more selective for BACE1 over BACE2.

What is the likelihood of BACE inhibitors providing clinical value to Alzheimer’s patients? originally appeared on Quora: the place to gain and share knowledge, empowering people to learn from others ...

CHARLOTTE, NC--(Marketwired - May 2, 2014) - BACE, a global manufacturer of vertical balers and compactors for use in the recycling and waste management industry, has hired Gregory J. Leon to the ...

The protein amyloid beta is believed to be the major cause of Alzheimer's disease. Substances that reduce the production of amyloid beta, such as BACE inhibitors, are therefore promising candidates ...

CHARLOTTE, N.C.--(BUSINESS WIRE)--BACE, LLC, a leading global equipment manufacturer, technology innovator and national service provider for the recycling and waste management industry, announces it ...

The aircraft display for the 2022 NBAA-BACE convention, with nearly 100 business aircraft on static display, at the Orlando Executive Airport, on Tuesday, October 18, 2022. The convention runs through ...